aluminum has been researched along with Tauopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, T; Hester, K; Kirrane, E; Kulikowski, N; Lehmann, DM; Simmons, JE | 1 |
| Ikeda, C; Ishihara, T; Nagao, S; Nakashima-Yasuda, H; Naohara, J; Oshima, E; Terada, S; Uchitomi, Y; Yokota, O | 1 |
2 other study(ies) available for aluminum and Tauopathies
| Article | Year |
|---|---|
Environmental exposure to metals and the development of tauopathies, synucleinopathies, and TDP-43 proteinopathies: A systematic evidence map protocol.
Topics: Aluminum; Antimony; Antineoplastic Combined Chemotherapy Protocols; Arsenic; Barium; Beryllium; Cadmium; Chromium; Cisplatin; Classification; Cobalt; Copper; Doxorubicin; Environmental Exposure; Humans; Manganese; Mercury; Mitomycin; Neurodegenerative Diseases; Nickel; Palladium; Radium; Review Literature as Topic; Silver; Synucleinopathies; Tauopathies; TDP-43 Proteinopathies; Vanadium; Zinc | 2022 |
Accelerated tau aggregation, apoptosis and neurological dysfunction caused by chronic oral administration of aluminum in a mouse model of tauopathies.
Topics: Administration, Oral; Aluminum; Animals; Apoptosis; Disease Models, Animal; Hippocampus; Mice; Mice, Transgenic; Movement; Spinal Cord; tau Proteins; Tauopathies | 2013 |